News

  • All
  • Announcements
  • Blog Posts
  • Media Highlights
  • Press Releases

06.05.2021

Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms

04.06.2021

Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production

03.23.2021

AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform

03.23.2021

The Science Advisory Board: AbSci secures $125M in financing

02.22.2021

AbSci Announces Strategic Investment by Merck Global Health Innovation Fund

02.03.2021

AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company

01.12.2021

AbSci Announces Acquisition of Deep Learning Company Denovium

01.07.2021

AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference

10.20.2020

GeekWire: Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech

Find out more

Contact Us

Translate ideas into impact

Explore current openings and get ready to prove that impossible isn’t.

Unlimit with us

© Copyright 2021 Absci Corp